Access to AIDS medicines and diagnostics
Access to diagnostic tests and medicines is an essential requirement to ensure the delivery of HIV prevention, treatment and care programmes. In order to support improved availability of HIV medicines and diagnostics, WHO convenes the AIDS Medicines and Diagnostics Service (AMDS), a network of technical partners providing support and guidance to countries in procurement and supply management of HIV commodities.
The main output of the AMDS is developing strategic information on HIV drugs and diagnostics, publishing an annual forecast on global demand for antiretrovirals (ARVs) and supporting capacity building activities for health supply chains.
2 December 2014
Publications on access to medicines
Global price reporting mechanism:
Database on procurement of HIV and hepatitis products
- Regulatory status of antiretroviral drugs
- Access to buprenorphine, methadone and oral morphine
- Access to medicines for opportunistic infections and palliative care
Active pharmaceutical ingredients of antiretroviral drugs: